Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice.

The roles played by the endogenous angiogenesis inhibitor thrombospondin-1 (TSP-1) in the early stages of multi-step carcinogenesis and in the control of hematogenous versus lymphatic metastasis are unknown. To investigate these issues we compared tumor development in normal mice and in transgenic m...

ver descrição completa

Detalhes bibliográficos
Principais autores: Hawighorst, T, Oura, H, Streit, M, Janes, L, Nguyen, L, Brown, L, Oliver, G, Jackson, D, Detmar, M
Formato: Journal article
Idioma:English
Publicado em: 2002